These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 16149873

  • 1. Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.
    Frick GS, Pitari GM, Weinberg DS, Hyslop T, Schulz S, Waldman SA.
    Expert Rev Mol Diagn; 2005 Sep; 5(5):701-13. PubMed ID: 16149873
    [Abstract] [Full Text] [Related]

  • 2. A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.
    Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA.
    Clin Cancer Res; 2006 Aug 01; 12(15):4545-52. PubMed ID: 16899600
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.
    Waldman SA, Barber M, Pearlman J, Park J, George R, Parkinson SJ.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun 01; 7(6):505-14. PubMed ID: 9641495
    [Abstract] [Full Text] [Related]

  • 4. Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.
    Chen G, McIver CM, Texler M, Lloyd JM, Rieger N, Hewett PJ, Sen Wan D, Hardingham JE.
    Dis Colon Rectum; 2004 May 01; 47(5):679-86. PubMed ID: 15037935
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues.
    Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD, Waldman SA.
    Proc Natl Acad Sci U S A; 1996 Dec 10; 93(25):14827-32. PubMed ID: 8962140
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Previstage GCC test for staging patients with colorectal cancer.
    Mejia A, Waldmana SA.
    Expert Rev Mol Diagn; 2008 Sep 10; 8(5):571-8. PubMed ID: 18785805
    [Abstract] [Full Text] [Related]

  • 12. Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications.
    Kong SL, Salto-Tellez M, Leong AP, Chan YH, Koay ES.
    J Clin Pathol; 2005 Aug 10; 58(8):839-44. PubMed ID: 16049286
    [Abstract] [Full Text] [Related]

  • 13. Previstage GCC colorectal cancer staging test: a new molecular test to identify lymph node metastases and provide more accurate information about the stage of patients with colorectal cancer.
    Carlson MR.
    Mol Diagn Ther; 2009 Aug 10; 13(1):11-4. PubMed ID: 19351210
    [Abstract] [Full Text] [Related]

  • 14. Molecular signature detection of circulating tumor cells using a panel of selected genes.
    Gervasoni A, Monasterio Muñoz RM, Wengler GS, Rizzi A, Zaniboni A, Parolini O.
    Cancer Lett; 2008 May 18; 263(2):267-79. PubMed ID: 18262345
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.
    Ann Surg Oncol; 2008 May 18; 15(5):1530-7. PubMed ID: 18259822
    [Abstract] [Full Text] [Related]

  • 17. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng TL, Chi CW, Wang JY.
    Ann Surg; 2007 Dec 18; 246(6):1040-6. PubMed ID: 18043108
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.
    Waldman SA, Cagir B, Rakinic J, Fry RD, Goldstein SD, Isenberg G, Barber M, Biswas S, Minimo C, Palazzo J, Park PK, Weinberg D.
    Dis Colon Rectum; 1998 Mar 18; 41(3):310-5. PubMed ID: 9514425
    [Abstract] [Full Text] [Related]

  • 20. Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
    Beaulieu M, Desaulniers M, Bertrand N, Deschesnes RG, Beaudry G, Garon G, Haince JF, Houde M, Holzer TJ.
    Diagn Mol Pathol; 2010 Mar 18; 19(1):20-7. PubMed ID: 20186008
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.